Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,177.9
-14.8 (-0.46%)

 

  • STI Straits Times Index
    3,177.9
    -14.8 (-0.46%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,685.7
    -16.4 (-0.96%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,001.2
    -4.2 (-0.02%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,576.7
    -3.0 (-0.12%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    20,593.7
    -29.2 (-0.14%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,477.0
    8.4 (0.13%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,124.5
    6.7 (0.32%)
    Index delayed 20 minutes
  • XAO XAO
    5,908.7
    -15.6 (-0.26%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 351.5M
  • Value: 488.6M
  • Rise: 97
  • Fall: 139
  • Unch: 611

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Genting Sing1.080-0.010
Rex Intl0.080+0.001
LionGold0.001-
ThaiBev0.730-0.005
HPH Trust USD0.245-0.010
Ezion0.051-
CapitaMall Trust2.300+0.030
Advance SCT0.001-
DeClout0.130-
Ascendas Reit2.670-0.040

World Indices

World Indices
Name Last Change
Nasdaq 7,020.4 -136.9
HSI 27,006.0 +0.5
HSCEI 10,630.5 +17.0
Jakarta 6,477.1 +8.5
Nikkei 225 20,593.7 -29.2
SSE Comp 2,579.0 -0.7
Shanghai A 2,700.6 -0.7
Shanghai B 276.8 -0.6
ShenZhen A 1,374.3 -0.3
ShenZhen B 863.6 +0.4
Taiwan W 9,846.4 -48.3
PSE Comp 0.0
KOSPI 2,127.0 +9.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 23 Jan 2019 10:30
Last (SGD): 0.230 Change: - High: - Remarks: -
Change (%): - Low: -
Open - Yesterday's Close 0.230
Buy Price 0.210 Sell Price 0.220
Buy Volume ('000) 60.0 Sell Volume ('000) 60.0
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a - Trailing EPS (SGD) e - NAV (SGD) b -0.1100
PE a - Trailing PE f - Price / NAV b -2.0909
Dividend (SGD) d - Cash In Hand (SGD) g - Issued & Paid-up Shares c 242,500,000
Dividend Yield (%) d - Price / Cash In Hand g - Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 55.775
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 55.775
Piotroski F Score - Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 6-Month VWAP n.a. Free Float (%) 99.7
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Service - Medical Specialties
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 20 Dec 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 55.775 0.077 - -2.0909 -
Industry Medical & Biotechnology SGX 1,114.244 22.675 21.089 1.4308 1.714
Medical Specialties SGX 730.171 29.152 29.112 4.1574 1.669
Local Peer Top Glove SGX 4,096.931 28.374 28.131 5.0585 1.774
Local Peer Yunnan Energy SGX 155.622 87.191 150.359 1.4009 -
Local Peer UG Healthcare SGX 40.593 9.362 8.993 0.9576 1.109
Local Peer Annica SGX 16.175 - - 2.5000 -
Local Peer Medtecs Intl SGX 15.933 13.488 17.394 0.1881 -
Global Peer ABBOTT LABORATORIES NYSE 125,560.032 268.295 143.991 4.0892 1.493
Global Peer MEDTRONIC PLC NYSE 116,844.480 37.643 51.678 2.3554 2.225
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 96,900.043 43.551 37.734 3.6036 0.248
Global Peer DANAHER CORP NYSE 74,583.088 29.928 27.016 2.6951 0.523
Global Peer BECTON DICKINSON & CO NYSE 64,450.224 405.345 405.347 3.0699 1.257
Global Peer STRYKER CORP NYSE 62,070.140 60.853 50.219 6.2951 1.053
Global Peer INTUITIVE SURGICAL INC NASDAQ 61,300.276 92.879 76.981 9.7603 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 51,560.388 495.742 76.956 6.2204 -
Global Peer BAXTER INTERNATIONAL INC NYSE 37,068.942 51.845 30.763 4.0601 0.891
Global Peer EDWARDS LIFESCIENCES CORP NYSE 35,180.856 60.282 49.384 10.4664 -
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), RESMED INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WATERS CORP (NYSE), ABIOMED INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), HAEMONETICS CORP (NYSE), ICU MEDICAL INC (NASDAQ), PENUMBRA INC (NYSE), INSULET CORPORATION (NASDAQ), LIVANOVA PLC (NASDAQ), HARTA (Bursa), NOVOCURE LTD (NASDAQ), GLOBUS MED INC (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), WEIGAO GROUP (HKEx), WRIGHT MEDICAL GROUP NV (NASDAQ), CANTEL MEDICAL CORP (NYSE), INOGEN INC (NASDAQ), NEOGEN CORP (NASDAQ), TOPGLOV (Bursa), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), GLAUKOS CORPORATION (NYSE), EBOS GROUP (ASX), AVANOS MEDICAL INC (NYSE), QUIDEL CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NXSTAGE MEDICAL INC (NASDAQ), CONMED CORP (NASDAQ), MICROPORT (HKEx), STAAR SURGICAL CO (NASDAQ), ATRION CORP (NASDAQ), NEVRO CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), ATRICURE INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), VAREX IMAGING CORPORATION (NASDAQ), CAREDX INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), LIFETECH SCI (HKEx), MESA LABORATORIES INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CERUS CORP (NASDAQ), VERICEL CORP (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), VIEWRAY INC (NASDAQ), NANOSONICS LIMITED (ASX), SURMODICS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), AXOGEN INC (NASDAQ), YESTAR HEALTH (HKEx), CIRC (HKEx), ESTABLISHMENT LABS HLDGS INC (NASDAQ), AK MEDICAL (HKEx), ORTHOPEDIATRICS CORP (NASDAQ), SI BONE INC (NASDAQ), QUOTIENT LTD (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), SIENTRA INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), GOLDEN MEDITECH (HKEx), VAPOTHERM INC (NYSE), APYX MEDICAL CORPORATION (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), IRADIMED CORP (NASDAQ), NUVECTRA CORPORATION (NASDAQ), NEURONETICS INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), PW MEDTECH (HKEx), INTRICOM CORP (NASDAQ), SUPERMX (Bursa), CYTOSORBENTS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CRH MEDICAL CORP (NYSE American), NEMAURA MEDICAL INC (NASDAQ), CORINDUS VASCULAR ROBOTICS INC (NYSE American), AVID BIOSERVICES INC (NASDAQ), CUTERA INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), ROCKWELL MEDICAL INC (NASDAQ), MISONIX INC (NASDAQ), MODERN DENTAL (HKEx), ELECTROCORE INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), INVACARE CORP (NYSE), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), FONAR CORP (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), YUNNAN ENERGY (HKEx), CORMEDIX INC (NYSE American), BIOTIME INC (NYSE American), RA MEDICAL SYSTEMS INC (NYSE), EKSO BIONICS HOLDINGS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), SOMNOMED LIMITED (ASX), ENDOLOGIX INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), ALPHA PRO TECH (NYSE American), IRIDEX CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), DAXOR CORP (NYSE American), CAS MEDICAL SYSTEMS (NASDAQ), SDI LTD (ASX), CYCLOPHARM LIMITED (ASX), ONCOCYTE CORP (NYSE American), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), VINCENT MED (HKEx), CELSION CORPORATION (NASDAQ), COMPUMEDICS (ASX), RESTORATION ROBOTICS INC (NASDAQ), ELECTROMED INC (NYSE American), IMMUCELL CORP (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), OBALON THERAPEUTICS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), CONFORMIS INC (NASDAQ), RESPIRI LTD (ASX), NEUROTROPE INC (NASDAQ), LIFE HEALTHCARE (HKEx), MICRO-X LTD (ASX), DARIOHEALTH CORP (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), BIOLASE INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), PAVMED INC (NASDAQ), AETHLON MEDICAL (NASDAQ), RESONANCE HEALTH LTD (ASX), OBJ LIMITED (ASX), BIOMERICA INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), NANOVIBRONIX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), DYNATRONICS CORP (NASDAQ), COMBEST HOLD (HKEx), CARDIEX LTD (ASX), HUAKANG BIOMED (HKEx), HANCOCK JAFFE LABORATORIES INC (NASDAQ), CYANOTECH CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), ADMEDUS LTD (ASX), AKERS BIOSCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), DIGIRAD CORP (NASDAQ), CHECK-CAP LTD (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OPTISCAN IMAGING (ASX), ADVENTA (Bursa), PRECISION THERAPEUTICS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), LKL (Bursa), ANALYTICA (ASX), MILESTONE SCIENTIFIC INC (NYSE American), USCOM LTD (ASX), LBT INNOVATIONS LTD (ASX), REALM THERAPEUTICS PLC SPONSORED ADS (NASDAQ), DIMERIX LTD (ASX), ONE HORIZON GROUP INC (NASDAQ), NEUROMETRIX INC (NASDAQ), PRESBIA PLC (NASDAQ), ITL HEALTH GROUP LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ATOSSA GENETICS INC (NASDAQ), AVINGER INC (NASDAQ), MICRON SOLUTIONS INC (NYSE American), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), CESCA THERAPEUTICS INC (NASDAQ), CH DEMETER FIN (HKEx), METALICITY LIMITED (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), CHF SOLUTIONS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGARD LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), MY MEDICARE (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.015
+6.98 %
10 Days -+0.010
+4.55 %
20 Days -+0.015
+6.98 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.180 - 0.265 Change From 1 Year Low +0.050 % Change From 1 Year Low (%) +27.78
Change From 1 Year High -0.035 % Change From 1 Year High (%) -13.21
2 Years Range 0.180 - 0.265 Change From 2 Years Low +0.050 % Change From 2 Years Low (%) +27.78
Change From 2 Years High -0.035 % Change From 2 Years High (%) -13.21
5 Years Range 0.180 - 0.265 Change From 5 Years Low +0.050 % Change From 5 Years Low (%) +27.78
Change From 5 Years High -0.035 % Change From 5 Years High (%) -13.21
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Incorporated in 2009, Biolidics is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring.

Biolidics has developed and commercialised the ClearCell® FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood.

Biolidics’ quality assurance capabilities have been recognised through its ISO 13485 certification, CE-IVD, US FDA Class I registration and CFDA Class I registration (for the MGI EasyCell System).

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) -17.86 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
22 Jan 2019 0.235 0.235 0.225 0.230 104,000 0.2331
21 Jan 2019 0.215 0.225 0.215 0.225 151,000 0.2164
18 Jan 2019 0.220 0.235 0.220 0.235 137,000 0.2284
17 Jan 2019 0.215 0.215 0.215 0.215 - -
16 Jan 2019 0.215 0.215 0.215 0.215 50,000 0.2150
15 Jan 2019 0.215 0.235 0.215 0.215 170,000 0.2171
14 Jan 2019 0.240 0.240 0.240 0.240 - -
11 Jan 2019 0.240 0.240 0.240 0.240 - -
10 Jan 2019 0.230 0.240 0.205 0.240 14,300 0.2297
09 Jan 2019 0.225 0.230 0.220 0.230 220,000 0.2256
08 Jan 2019 0.220 0.220 0.220 0.220 129,000 0.2200
07 Jan 2019 0.200 0.225 0.200 0.225 1,100 0.2023
04 Jan 2019 0.215 0.220 0.215 0.215 237,000 0.2197
03 Jan 2019 0.220 0.220 0.210 0.210 102,000 0.2198
02 Jan 2019 0.220 0.220 0.220 0.220 - -
31 Dec 2018 0.200 0.220 0.183 0.220 66,200 0.1934
28 Dec 2018 0.230 0.230 0.230 0.230 - -
27 Dec 2018 0.220 0.230 0.193 0.230 289,200 0.2100
26 Dec 2018 0.240 0.240 0.181 0.220 241,000 0.2194
24 Dec 2018 0.182 0.215 0.180 0.215 70,100 0.1827
21 Dec 2018 0.200 0.235 0.186 0.200 607,800 0.1987
20 Dec 2018 0.215 0.215 0.199 0.205 509,400 0.2035
Summary
Current 2 Weeks
(09 Jan 2019 to 22 Jan 2019)
0.225 0.240 0.205 0.230 846,300 -
Previous 2 Weeks
(24 Dec 2018 to 08 Jan 2019)
0.182 0.240 0.180 0.220 1,135,600 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.